AI assistant
Sending…
Boule Diagnostics — Major Shareholding Notification 2017
Jan 17, 2017
3143_iss_2017-01-17_ffb56c17-8fbb-4b55-b3a6-713f6279a49b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Boule Diagnostic AB
Holder
195605 Staffan Persson
Instrument
| Instrument | Shares SE0000437402 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 13/01/2017 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 0 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 0 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first | ||
| paragraph, line 2 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total |
Chain of controlling companies
Voting rights % Voting rights Company
0 0 Zimbrine Holding BV
Group total holdings
Voting rights 0 Percentage of voting rights 0
Published
17/01/2017 11:26
Contact Name Staffan Persson
Phone 0703210098 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Boule Diagnostics
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Annual Report
2026
Apr 10
Interim / Quarterly Report
2026
Feb 11
Earnings Release
2026
Feb 11
Board/Management Information
2025
Dec 30
Board/Management Information
2025
Dec 30